15 Osteogenesis Imperfecta Clinical Trials in Scottsdale, AZ (2026)

Q: How do I join a clinical trial in Scottsdale?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Scottsdale research site will contact you.

Recruiting Osteogenesis Imperfecta Studies in Scottsdale

NCT05112614Recruiting

Role of Gut Microbiome in Cancer Therapy

This study examines how gut microbiome can affect cancer therapy in cancer patients undergoing cancer therapy or stem cell transplant. The human microbiome affects the way some cancer drugs are metabo...

Scottsdale, AZ3,000 participantsMayo Clinic

View Study Details

NCT02958462Recruiting

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

This clinical trial tests next generation sequencing (NGS) for the detection of precursor features of pre-myeloid cancers and bone marrow failure syndromes. NGS is a procedure that looks at relevant c...

Scottsdale, AZ2,000 participantsMayo Clinic

View Study Details

NCT06353191Recruiting

Biomarkers to Predict Cancer Therapy-related Cardiotoxicity

This study evaluates why some cancer patients but not others experience changes in heart function following treatment with chemotherapy....

Scottsdale, AZ1,000 participantsMayo Clinic

View Study Details

NCT06198010Recruiting

A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors

This clinical trial tests a collaborative pain management intervention (ASCENT) for improving cancer pain in cancer survivors. Cancer pain is prevalent, under-treated, and remains a major cause of suf...

Scottsdale, AZ660 participantsMayo Clinic

View Study Details

NCT06207188Recruiting

Identification and Differentiation of Thyroid Nodules by Acoustic Imaging and Viscoelastic Parameters

This study is being done to identify and differentiate thyroid nodules by acoustic imaging and viscoelastic parameters....

Scottsdale, AZ650 participantsMayo Clinic

View Study Details

NCT05208047Recruiting

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

This is a Phase 3, open-label, international, multicenter study of CGT9486 in combination with sunitinib. This is a multi-part study that will enroll approximately 482 patients. Part 1 consists of two...

Scottsdale, AZ482 participantsCogent Biosciences, Inc.

View Study Details

NCT06569316Recruiting

Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)

This clinical trial is studying the genetic changes in cells associated with different types of cancer in Indigenous American (IA) populations in the Southwest to improve cancer screening, precision p...

Scottsdale, AZ300 participantsMayo Clinic

View Study Details

NCT06246955Recruiting

Acceptance and Commitment Therapy and Compassion-Based Virtual Group Therapy to Improve Psychological Wellbeing in Patients With Cancer

This clinical trial tests how well acceptance and commitment therapy and compassion based virtual group therapy works to improve psychological wellbeing, such as compassion, understanding, and flexibi...

Scottsdale, AZ200 participantsMayo Clinic

View Study Details

NCT06880861Recruiting

Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers

This study evaluates relationships among physical activity, thinking, and memory after cancer treatment in survivors of adolescent and young adult cancers....

Scottsdale, AZ100 participantsMayo Clinic

View Study Details

NCT05898646Recruiting

Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial

This phase II trial compares shorter-duration versus longer-duration maintenance therapy with daratumumab for improving survival in patients who have received initial treatment with daratumumab for li...

Scottsdale, AZ96 participantsMayo Clinic

View Study Details

NCT06279572Recruiting

Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy

This study investigates the immune profile of patients receiving treatment with venetoclax plus azacitidine for acute myeloid leukemia (AML). Studying the information gathered from the immune profile ...

Scottsdale, AZ80 participantsMayo Clinic

View Study Details

NCT05584449Recruiting

Group Curriculum for Improving Survivorship Outcomes in Adolescent and Young Adult Cancer Survivors

This clinical trial studies the effectiveness of a group curriculum in improving survivorship outcomes in adolescent and young adult (AYA) cancer survivors. Many AYA survivors typically do not feel pr...

Scottsdale, AZ60 participantsMayo Clinic

View Study Details

NCT06201416Recruiting

Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

This study will test the safety and effects of SBT777101 when given as a single dose to subjects with rheumatoid arthritis. It is the first study of this treatment being done in humans. Increasing dos...

Scottsdale, AZ48 participantsSonoma Biotherapeutics, Inc.

View Study Details

NCT06712810Recruiting

Q702 for the Treatment of Patients With Hematologic Malignancies

This phase I trial tests the safety, side effects, and best dose of Q702 in treating patients with hematologic malignancies. Q702 is in a class of medications called immunomodulatory agents. It works ...

Scottsdale, AZ46 participantsMayo Clinic

View Study Details

NCT05647265Recruiting

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

This phase II trial evaluates the safety and effectiveness of giving immunotherapy (nivolumab and ipilimumab) before surgery for controlling disease in patients with stage I-IIIa sarcomatoid mesotheli...

Scottsdale, AZ26 participantsAlliance for Clinical Trials in Oncology

View Study Details

About Osteogenesis Imperfecta Clinical Trials in Scottsdale

Osteogenesis imperfecta is a group of genetic disorders mainly affecting the bones, causing them to break easily, often from little or no apparent cause. It is caused by defects in collagen production. Treatment includes bisphosphonates, physical therapy, and surgical rodding.

There are currently 15 osteogenesis imperfecta clinical trials recruiting participants in Scottsdale, AZ. These studies are seeking a combined 8,748 participants. Research is being sponsored by Mayo Clinic, Cogent Biosciences, Inc., Sonoma Biotherapeutics, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Osteogenesis Imperfecta Clinical Trials in Scottsdale — FAQ

Are there osteogenesis imperfecta clinical trials in Scottsdale?

Yes, there are 15 osteogenesis imperfecta clinical trials currently recruiting in Scottsdale, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Scottsdale?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Scottsdale research site will contact you about next steps.

Are clinical trials in Scottsdale free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Scottsdale studies also compensate for your time and travel.

What osteogenesis imperfecta treatments are being tested?

The 15 active trials in Scottsdale are testing new therapies including novel drugs, biologics, and treatment approaches for osteogenesis imperfecta.

Data updated July 13, 2026 from ClinicalTrials.gov